4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002675
Options or other derivatives
- Chief Operating Officer acquired 789,024 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bertrand William C JR Chief Operating Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +644,976 | 644,976 | D | ||
| Bertrand William C JR Chief Operating Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +144,048 | 144,048 | D | ||
Loading xslF345X03/a4.xml…